Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 02, 2025
Porton Pharma Solutions and Dragon Sail Pharmaceutical Co., Ltd. signed a strategic cooperation agreement in Guilin, southern of China. This collaboration aims to carry out in-depth cooperation in the research, development, production, and supply ...
read more
Monday, February 05, 2018
Portage announced its subsidiary, PPL, has formed a new joint venture company to develop more effectively-targeted drugs to treat chronic conditions including cancer.
read more
Friday, December 11, 2015
Porsolt SAS, a preclinical in vivo efficacy and safety CRO, has acquired Fluofarma, a Bordeaux-based company focused on the provision of cell-based assays and in vitro screening services.
read more
Thursday, January 23, 2025
Polyrizon Ltd. has commenced preliminary work related to the Good Manufacturing Practice (GMP) manufacturing process for its PL-14 allergy blocker in preparation for its planned 2025 clinical trial. The company works closely with Eurofins CDMO, ...
read more
Wednesday, March 06, 2024
Polyplus (part of Satorius) company, Xpress Biologics, has received a good manufacturing practice (GMP) certification for recombinant protein production and renewed the January 2023 GMP certification for DNA production at the facility located in ...
read more
Friday, December 09, 2022
Polyplus has announced the completed acquisition of Xpress Biologics, a Belgian contract development and manufacturing organization (CDMO) specialized in the production of plasmid DNA and protein using microbial expression systems.
read more
The PolyPeptide Group has partnered with Novavax on large-scale GMP production of a critical component of Novavax’ novel coronavirus vaccine candidate, NVX-CoV2373.
read more
Wednesday, January 04, 2017
The PolyPeptide Group announced that the acquisition of the peptides business and operations of Lonza in Braine-l'Alleud, Belgium has been completed. The Braine facility, with approximately 280 employees, was the center for peptide chemical ...
read more
Monday, September 09, 2019
Polpharma Biologics has entered a global commercialization agreement with Sandoz AG for a natalizumab biosimilar.
read more
Wednesday, March 18, 2020
The FDA is issuing this guidance to provide a policy to help accelerate the availability of novel coronavirus tests developed by laboratories and commercial manufacturers during the public health emergency.
read more
PolarityTE announced the acquisition of a preclinical biomedical research facility in order to accelerate research and development of PolarityTE pipeline products.
read more
Thursday, September 19, 2019
PMRS has filed a petition asking the U.S. Court of Appeals for the District of Columbia Circuit to overturn the FDA's refusal to approve a new opioid capsule intended to deter abuse.
read more
Premier Medical Laboratory Services (PMLS) are now validated for COVID-19 testing.
read more
PMI Biopharma Solutions and Nashville Biosciences announced a strategic collaboration to provide their customers with an integrated product offering around drug discovery and development.
read more
Thursday, November 01, 2018
PMI BioPharma Solutions announced that David Sunseri, PhD has been appointed Chief Executive Officer effective August 2018.
read more